Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARCA biopharma

28.80
+0.0000
Volume:- -
Turnover:688.27K
Market Cap:849.32M
PE:-57.85
High:28.80
Open:28.80
Low:28.80
Close:28.80
Loading ...
Jun 19, 2024

Correspondence

Form CORRESP - Correspondence
Jun 06, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 29, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 23, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 05, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Apr 04, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report